Clinical Trials Browser

Phase 2/3 × Hematologic Neoplasms × Imipenem × Clear all

NCT03733340 2018-11-07

Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT

Phase 2/3 Unknown

Other hematologic neoplasm

Hematologic Neoplasms